All In Biotech

Drug Trial Radar · NCT01430195

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)

Proof of Concept Study to Compare Efficacy and Safety of Subcutaneous, Bioresorbable Afamelanotide Implants and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Nonsegmental Vitiligo

Last checked: Nov 20, 2026Latest source record: Mar 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

56

Actual

Start

Jun 2011

Primary completion

May 2012

Study completion Nov 2012

Sponsor

Sponsor type
Industry
First posted
Sep 8, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to look at the efficacy of afamelanotide, when combined with narrow-band ultraviolet B (NB-UVB) light, in patients with nonsegmental vitiligo. Afamelanotide is expected to speed up the repigmentation induced by NB-UVB light, leading to reducing frequency and doses of NB-UVB.

Conditions

  • Vitiligo

Interventions

  • AfamelanotideDrug

    NB-UVB phototherapy with or without subcutaneous, bioresorbable Afamelanotide 16 mg implants, contained in a poly(D,L-lactide-co-glycolide) implant core released over 7-10 days following implantation Other Name: CUV1647

  • Narrow-Band UVB Light TreatmentProcedure

    To be administered 3 times/week for 6 months. 72 treatments in total.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pigmentation of full body, face, trunk and extremities using the VASI and VETF scoresTime frame: 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Henry Ford Medical Center

    Detroit, Michigan

  • The Mount Sinai School of Medicine

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.